Videos

Joseph Eron, MD, explains how some individuals acquire resistance to HIV therapy and discusses new drugs in the pipeline that are effective against resistant virus.

Colleen Kelley, MD, stresses the importance of routinizing HIV testing and shares what physicians can do if their patient declines the option to get tested.

Debra Goff, PharmD, FCCP, explains how mobile apps are being used by health care providers to improve patient outcomes.

Barley Chironda, RPN, CIC, infection control specialist at Clorox Healthcare, explains how cell phones and smart devices can potentially serve as a vector for C. diff.

Joseph Eron, MD, discusses when clinicians may expect to have access to long-acting injectable ART and the different opportunities it offers for individuals with HIV.

Colleen Kelley, MD, explains what is needed to ensure that individuals get tested for HIV.

Marin H. Kollef, MD, discusses the strongest approach for treating Pseudomonas infections.

Barley Chironda, RPN, CIC, explains why current environmental disinfection practices aren’t making the cut.

Debra Goff, PharmD, FCCP, discusses how the STAB-IT app helps health care providers with real-time point-of-care management of Staphylococcus aureus bacteremia.

Experts in the field of HIV provide their key takeaways from CROI 2018.

Jonathan Colasanti, MD, MSPH, shares how the introduction of a Rapid Entry Program in Atlanta proved successful at improving access to HIV care and viral suppression rates.

Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.

Debra Goff, PharmD, FCCP, explains how technology can be incorporated into antimicrobial stewardship programs.

Barley Chironda, RPN, CIC, discusses different high-touch surfaces in hospital rooms that are known to harbor pathogenic bacteria.

Marin H. Kollef, MD, discusses treatment options for Pseudomonas aeruginosa.

Glenn Tillotson, PhD, FIDSA, provides insight into the growing problem and cost of antimicrobial resistance.

Leonard Sigal, MD, explains his approach for treating Lyme disease patients with persistent symptoms.

Dr. Richard Vickers, discusses what the next steps are for Summit Therapeutic’s ridinilazole.

Marin H. Kollef, MD, discusses what to consider when calling for cultures.

Debra Goff, PharmD, FCCP, explains the role that antimicrobial stewardship programs have in the fight against multidrug-resistant infections.

Edmond Hooker, MD, DrPH, stresses that the FDA and the CDC need to intervene to ensure that hospital mattresses get cleaned appropriately.

Barley Chironda, RPN, CIC, stresses that understanding what motivates health care workers’ actions is crucial for reducing C. diff rates in hospitals.

Glenn Tillotson, PhD, FIDSA, explains how costs associated with Clostridium difficile compare with other problematic health care-associated infections.

Marin H. Kollef, MD, explains why Pseudomonas infections are getting harder to treat.

Richard Haupt, MD, MPH, explains why it’s harder to cover adults rather than children when it comes to vaccination.

Edmond Hooker, MD, DrPH, discusses a study that assessed the use of mattress covers in hospitals to cut down on CDI rates.

Barley Chironda, RPN, CIC, discusses why some health care workers are not practicing good hand hygiene and ways to motivate them to do so.

Dr. Richard Vickers, explains how ridinilazole affected the gut microbiome in participants of a phase 2 study.

Leonard Sigal, MD, explains his approach for treating patients who may have “Lyme anxiety.”

Marin H. Kollef, MD, discusses Pseudomonas aeruginosa infections within the intensive care unit.